While PROK1 did not show significant differential expression in pancreatic cancer, we observed that it was significantly downregulated in tumors from colon cancer (COAD) and ovarian cancer (OV) patients compared to their corresponding normal tissues (Figure 10A). Here, PROK1 is linked to ovarian carcinoma.